These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 21664880

  • 1. The effect of varenicline on heart rate variability in healthy smokers and nonsmokers.
    Ari H, Celiloğlu N, Ari S, Coşar S, Doganay K, Bozat T.
    Auton Neurosci; 2011 Oct 28; 164(1-2):82-6. PubMed ID: 21664880
    [Abstract] [Full Text] [Related]

  • 2. The effect of varenicline on Tp-e interval, Tp-e/QT ratio and Tp-e/QTc ratio in healthy smokers and nonsmokers.
    Ari H, Ari S, Coşar S, Celiloğlu N, Aktaş İ, Camci S, Doğanay K, Tütüncü A, Melek M.
    Cardiol J; 2015 Oct 28; 22(5):551-6. PubMed ID: 26100824
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers.
    Kikkawa H, Maruyama N, Fujimoto Y, Hasunuma T.
    J Clin Pharmacol; 2011 Apr 28; 51(4):527-37. PubMed ID: 20551220
    [Abstract] [Full Text] [Related]

  • 5. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    McColl SL, Burstein AH, Reeves KR, Billing CB, Stolar M, Sellers EM.
    Clin Pharmacol Ther; 2008 Apr 28; 83(4):607-14. PubMed ID: 18288085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
    Bolliger CT, Issa JS, Posadas-Valay R, Safwat T, Abreu P, Correia EA, Park PW, Chopra P.
    Clin Ther; 2011 Apr 28; 33(4):465-77. PubMed ID: 21635992
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.
    Arch Intern Med; 2011 Apr 28; 166(15):1571-7. PubMed ID: 16908789
    [Abstract] [Full Text] [Related]

  • 9. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C.
    Biol Psychiatry; 2010 Apr 15; 67(8):715-21. PubMed ID: 20207347
    [Abstract] [Full Text] [Related]

  • 10. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S.
    Respirology; 2009 Apr 15; 14(3):384-92. PubMed ID: 19192221
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of dopamine type-2 receptor blockade on autonomic modulation.
    Kaya D, Ellidokuz E, Onrat E, Ellidokuz H, Celik A, Kilit C.
    Clin Auton Res; 2003 Aug 15; 13(4):275-80. PubMed ID: 12955552
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials.
    Ware JH, Vetrovec GW, Miller AB, Van Tosh A, Gaffney M, Yunis C, Arteaga C, Borer JS.
    Am J Ther; 2013 Aug 15; 20(3):235-46. PubMed ID: 23615317
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control.
    Kaya D, Barutcu I, Esen AM, Onrat E, Orman A, Unlu M.
    Europace; 2004 Nov 15; 6(6):602-7. PubMed ID: 15519264
    [Abstract] [Full Text] [Related]

  • 16. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
    Park PW, Casiano EM, Escoto L, Claveria AM.
    Curr Med Res Opin; 2011 Oct 15; 27(10):1869-75. PubMed ID: 21838412
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.
    Burstein AH, Fullerton T, Clark DJ, Faessel HM.
    J Clin Pharmacol; 2006 Nov 15; 46(11):1234-40. PubMed ID: 17050788
    [Abstract] [Full Text] [Related]

  • 18. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S, Patel PN.
    Cardiol Rev; 2007 Nov 15; 15(3):154-61. PubMed ID: 17438382
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers.
    Zhao Q, Schwam E, Fullerton T, O'Gorman M, Burstein AH.
    J Clin Pharmacol; 2011 Apr 15; 51(4):492-501. PubMed ID: 20466870
    [Abstract] [Full Text] [Related]

  • 20. [The effect of orthostatic provocation on the spectral pattern of heart rate variability in healthy subjects].
    Rozentryt P, Trzos G, Strłojewski D, Kozlowski JW, Maciejewski M.
    Przegl Lek; 1996 Apr 15; 53(7):534-9. PubMed ID: 8975288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.